Donate
Members
About Us
About ANZCHOG
Board of Directors
Our People
Our Members
Supporters & Partners
The Challenges of Childhood Cancer
Clinical Trials & Research
Clinical Trials
Clinical Trial Support
Research
ANZCHOG Biobanking Network
ANZCHOG Children’s Cancer Clinical Trials Repository
Collaborations
Brain Cancer Mission
Background
Trials Advisory Group
Clinical Trials Supported
ASM
News
Events
Contact Us
Australian & New Zealand Childrens Haematology/Oncology Group
Donate
Members
About Us
About ANZCHOG
Board of Directors
Our People
Our Members
Supporters & Partners
The Challenges of Childhood Cancer
Clinical Trials & Research
Clinical Trials
Clinical Trial Support
Research
ANZCHOG Biobanking Network
ANZCHOG Children’s Cancer Clinical Trials Repository
Collaborations
Brain Cancer Mission
Background
Trials Advisory Group
Clinical Trials Supported
ASM
News
Events
Contact Us
Clinical Trials
Home
Clinical Trials & Research
Clinical Trials
Viewing: Clinical Trials
Filter by
Closed to Recruitment
Preparing to Open
Open
In Development
Hypermutant Cancers
Status:
Closed to Recruitment
|
NSW , QLD , SA
Hypermutant Cancers Trial: A Pilot Study of Nivolumab in Paediatric Patients with Hypermutant Cancers
Read more
Brain cancer: Medulloblastoma
Status:
Closed to Recruitment
SJ ELiOT: Phase 1 Evaluation of LY2606368, a CHK inhibitor, in combination with cyclophosphamide or gemcitabine for children & adolescents with recurrent medulloblastoma tumours.
Read more
Brain and solid tumours
Status:
Closed to Recruitment
COZMOS: Phase I/Ib trial of Combined 5’azacitidine and carboplatin for recurrent/refractory paediatric brain and solid tumours
Read more
High risk haematological malignancy, or a non-malignant disease
Status:
Closed to Recruitment
Pαβlo: Paediatric αβ haploidentical transplantation
Read more
High-risk cancers
Status:
Open
|
NSW , QLD , TAS , VIC , WA , SA
PRISM: PRecISion Medicine for Children with Cancer
Read more
Leukaemia, solid tumours and brain tumours
Status:
Closed to Recruitment
|
NSW , QLD , VIC , WA , SA
PARC: An international phase I/II study evaluating the safety and activity of Pegylated recombinant human Arginase (BCT-100) in Relapsed/refractory cancers of Children and young adults.
Read more
First
Previous
2
3
4
5
6
Next
Last
All posts loaded.
All posts loaded.
Load more trials